Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alexithymia Intervention for Suicide (ALEXIS)

NCT05724953 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05724953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05724953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alexithymia Intervention for Suicide (ALEXIS)
Lead sponsor
VA Office of Research and Development
Phase
Phase 1
Overall status
Terminated
Start date
October 1, 2023
Completion date
January 30, 2026
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, major depressive disorder, post traumatic stress disorder, schizophrenia, suicide